Board-Certified Endocrinologist, Clinical Researcher & Medical Reviewer
Bridging the Gap Between Cutting-Edge Research and Patient Care
When it comes to managing a complex chronic condition like diabetes, having access to accurate, up-to-date medical information is just as important as the medication you take. That is where David T. Broome, MD, MS comes in.
As a Clinical Assistant Professor of Medicine in the Metabolism, Endocrinology, and Diabetes (MEND) Division at the University of Michigan, Dr. Broome sits at the exact intersection of groundbreaking clinical research and compassionate, everyday patient care.
For the MyGlu community, he serves as a vital medical resource, reviewing our content to ensure it meets the highest standards of clinical accuracy and safety.
Unmatched Clinical & Academic Credentials
Dr. Broome’s expertise is built on a foundation of rigorous academic training and elite clinical fellowships. He is board-certified in both Internal Medicine and Endocrinology, Diabetes & Metabolism.
- Medical Degree (MD): Wayne State University School of Medicine
- Master of Science (MS): Health and Healthcare Research, University of Michigan
- Residency & Fellowship: Internal Medicine and Endocrinology at the world-renowned Cleveland Clinic Foundation
He is an active member of the Institute for Healthcare Policy and Innovation (IHPI), the AI and Digital Health Innovation Center, and the Caswell Diabetes Institute at the University of Michigan.
Leading the Charge in Diabetes Research
Dr. Broome is not just treating diabetes; he is actively helping to shape its future. His clinical and research interests focus heavily on Type 1 diabetes (T1D) screening and prevention, atypical diabetes, and Monogenic Diabetes (MODY)
He is a principal investigator for several major NIH/NIDDK and industry-sponsored clinical trials, including:
- TrialNet: The leading clinical trial network for T1D prevention and screening.
- RADIANT: The Rare and Atypical Diabetes Network.
- PREDICT: The largest multi-center MODY data collaboration in the United States, which Dr. Broome Co-Chairs.
- PRECIDENTD: A long-term safety study for TZIELD (teplizumab), the first FDA-approved immunotherapy to delay the onset of Stage 3 T1D.
His research on novel therapeutics, such as the use of dual GIP/GLP-1 receptor agonists in specific types of diabetes, is regularly published in top-tier, peer-reviewed medical journals like the Journal of Clinical Endocrinology & Metabolism (JCEM) and Diabetes Care.
He also serves on the editorial board for Frontiers in Clinical Diabetes and Healthcare and is the Co-Chair of the Publications Committee for the T1D Exchange
A Doctor Who Truly Listens
While his academic resume is staggering, Dr. Broome’s most important credential is how he treats his patients. He holds a remarkable 4.9 out of 5-star patient rating based on nearly 200 reviews.
His patients frequently highlight his rare combination of deep medical knowledge and genuine human empathy.
As one patient noted, “Dr. Broome stands out among caregivers. He listens carefully, explains things clearly… He’s one of the best doctors I’ve ever had.” Another shared, “He doesn’t rush us. He is thorough, very explanatory, and talks to patients with verbiage they can understand.”
At MyGlu, Dr. Broome brings this exact same clarity and compassion to his medical reviews, ensuring that complex medical jargon is translated into plain, actionable English for our readers.
Life Outside the Clinic
When he is not seeing patients at the University of Michigan’s Brighton or Ann Arbor clinics or analyzing data for the PREDICT consortium, Dr. Broome stays active. He is an avid ice hockey player and cyclist. He also loves spending quality time with his family and friends relaxing on the beach in Holland, Michigan.
Connect with Dr. Broome’s Professional Work
- Clinical Profile: University of Michigan Health
- Physician Network: Doximity Profile
- Research & Publications: PubMed / NCBI
- Academic Expertise: U-M Experts Directory
⚠️ Medical Disclaimer
The content authored and reviewed by David T. Broome, MD, on MyGlu is for general educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Dr. Broome’s reviews ensure that information regarding diabetes mechanisms, medications, and technologies is clinically accurate based on current evidence. However, this content should never replace a consultation with your own endocrinologist or primary care physician. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition, medication dosages, or before starting any new diet, supplement, or exercise program.